Abiopharma

🔍 Kulkarni Amol (Director)

Company: Dynatrace, Inc. (DT)

Report Date: 2026-08-20

Detailed Transactions and Holdings:

• Acquired 4,111 shares of Common Stock (Direct)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 13,799.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 4,111 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2, F1

Footnotes:

• F1: Each time-based restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs do not expire. They either vest or are cancelled prior to the vesting date.
• F2: Represents the vesting of RSUs granted on August 20, 2025 under the Issuer's 2019 Equity Incentive Plan, as amended, and the Amended and Restated Non-Employee Director Compensation Policy. 100% of these RSUs vested on August 20, 2026, which was the earlier of the one-year anniversary of the date of grant (August 20, 2026) and the date of the Issuer's 2026 Annual Meeting of Stockholders (scheduled to be held on August 26, 2026).